Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 4771

1.

Lower urinary tract dysfunction in patients with parkinsonism and other neurodegenerative disorders.

Winge K.

Handb Clin Neurol. 2015;130:335-356. doi: 10.1016/B978-0-444-63247-0.00019-5.

PMID:
26003253
2.

Laquinimod therapy in multiple sclerosis: a comprehensive review.

Kolb-Sobieraj C, Gupta S, Weinstock-Guttman B.

Neurol Ther. 2014 May 6;3(1):29-39. doi: 10.1007/s40120-014-0017-6. eCollection 2014 Jun. Review.

3.

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders.

Herbert MK, Aerts MB, Beenes M, Norgren N, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM.

Front Neurol. 2015 May 5;6:91. doi: 10.3389/fneur.2015.00091. eCollection 2015.

5.

Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.

Wang X, Yu S, Li F, Feng T.

Neurosci Lett. 2015 May 18. pii: S0304-3940(15)00387-0. doi: 10.1016/j.neulet.2015.05.030. [Epub ahead of print]

PMID:
25998655
6.

Differences in early speech patterns between Parkinson variant of multiple system atrophy and Parkinson's disease.

Huh YE, Park J, Suh MK, Lee SE, Kim J, Jeong Y, Kim HT, Cho JW.

Brain Lang. 2015 May 18;147:14-20. doi: 10.1016/j.bandl.2015.04.007. [Epub ahead of print]

PMID:
25997172
7.

Filamentous aggregations of phosphorylated α-synuclein in Schwann cells (Schwann cell cytoplasmic inclusions) in multiple system atrophy.

Nakamura K, Mori F, Kon T, Tanji K, Miki Y, Tomiyama M, Kurotaki H, Toyoshima Y, Kakita A, Takahashi H, Yamada M, Wakabayashi K.

Acta Neuropathol Commun. 2015 May 21;3(1):29. doi: 10.1186/s40478-015-0208-0.

8.

Olfactory function combined with morphology distinguishes Parkinson's disease.

Sengoku R, Matsushima S, Bono K, Sakuta K, Yamazaki M, Miyagawa S, Komatsu T, Mitsumura H, Kono Y, Kamiyama T, Ito K, Mochio S, Iguchi Y.

Parkinsonism Relat Disord. 2015 May 11. pii: S1353-8020(15)00197-2. doi: 10.1016/j.parkreldis.2015.05.001. [Epub ahead of print]

PMID:
25986741
9.

Higher BMI is associated with reduced brain volume in heart failure.

Alosco ML, Brickman AM, Spitznagel MB, Narkhede A, Griffith EY, Raz N, Cohen R, Sweet LH, Colbert LH, Josephson R, Hughes J, Rosneck J, Gunstad J.

BMC Obes. 2014 Dec 1;1(1):4.

10.

Fluid biomarkers in multiple system atrophy: A review of the MSA Biomarker Initiative.

Laurens B, Constantinescu R, Freeman R, Gerhard A, Jellinger K, Jeromin A, Krismer F, Mollenhauer B, Schlossmacher MG, Shaw LM, Verbeek MM, Wenning GK, Winge K, Zhang J, Meissner WG.

Neurobiol Dis. 2015 May 15. pii: S0969-9961(15)00166-7. doi: 10.1016/j.nbd.2015.05.004. [Epub ahead of print] Review.

PMID:
25982836
11.

Expanding the spectrum of neuronal pathology in multiple system atrophy.

Cykowski MD, Coon EA, Powell SZ, Jenkins SM, Benarroch EE, Low PA, Schmeichel AM, Parisi JE.

Brain. 2015 May 16. pii: awv114. [Epub ahead of print]

PMID:
25981961
12.

Association Analysis of COQ2 Variant in Dementia and Essential Tremor.

Chao YX, Ng EY, Li H, Nagaendran K, Yih Y, Chong MS, Prakash KM, Tan L, Au WL, Zhao Y, Zhou ZD, Tio M, Pavanni R, Tan EK.

Parkinsons Dis. 2015;2015:926280. doi: 10.1155/2015/926280. Epub 2015 Apr 22.

13.

New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study.

Pavy-Le Traon A, Piedvache A, Perez-Lloret S, Calandra-Buonaura G, Cochen-De Cock V, Colosimo C, Cortelli P, Debs R, Duerr S, Fanciulli A, Foubert-Samier A, Gerdelat A, Gurevich T, Krismer F, Poewe W, Tison F, Tranchant C, Wenning G, Rascol O, Meissner WG; European MSA Study Group.

J Neurol Neurosurg Psychiatry. 2015 May 14. pii: jnnp-2014-309999. doi: 10.1136/jnnp-2014-309999. [Epub ahead of print]

PMID:
25977316
14.

Oligodendroglia and Myelin in Neurodegenerative Diseases: More Than Just Bystanders?

Ettle B, Schlachetzki JC, Winkler J.

Mol Neurobiol. 2015 May 13. [Epub ahead of print]

PMID:
25966971
15.
16.

Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein.

Aoki N, Boyer PJ, Lund C, Lin WL, Koga S, Ross OA, Weiner M, Lipton A, Powers JM, White CL 3rd, Dickson DW.

Acta Neuropathol. 2015 May 12. [Epub ahead of print]

PMID:
25962793
17.

Heat shock protein 70 overexpression does not attenuate atrophy in Botulinum neurotoxin type A treated skeletal muscle.

Houston FE, Hain BA, Adams TJ, Houston KL, O'Keeffe R, Dodd SL.

J Appl Physiol (1985). 2015 May 7:jap.00233.2015. doi: 10.1152/japplphysiol.00233.2015. [Epub ahead of print]

PMID:
25953835
18.

Isopentenyl diphosphate isomerase, a cholesterol synthesizing enzyme, is localized in Lewy bodies.

Nakamura K, Mori F, Tanji K, Miki Y, Yamada M, Kakita A, Takahashi H, Utsumi J, Sasaki H, Wakabayashi K.

Neuropathology. 2015 May 7. doi: 10.1111/neup.12204. [Epub ahead of print]

PMID:
25950736
19.

Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy.

Haga R, Sugimoto K, Nishijima H, Miki Y, Suzuki C, Wakabayashi K, Baba M, Yagihashi S, Tomiyama M.

Parkinsons Dis. 2015;2015:167038. doi: 10.1155/2015/167038. Epub 2015 Apr 6.

20.

Laser arytenoidectomy and posterior cordotomy in a patient with bilateral vocal cord paralysis due to multiple system atrophy.

Mahmud A, Strens LH, Tedla M.

BMJ Case Rep. 2015 May 4;2015. pii: bcr2014206156. doi: 10.1136/bcr-2014-206156.

PMID:
25939970
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk